Connect with us

Health

The Women Most Affected by Abortion Bans

Published

on

The Women Most Affected by Abortion Bans

Abortion bans successfully prevented some women from getting abortions in the immediate aftermath of the Supreme Court’s overturning of Roe v. Wade, according to a detailed new study of birth data from 2023. The effects were most pronounced among women in certain groups — Black and Hispanic women, women without a college degree, and women living farthest from a clinic.

Abortion has continued to rise since the period the data covers, especially through pills shipped into states with bans. But the study identifies the groups of women who are most likely to be affected by bans.

For the average woman in states that banned abortion, the distance to a clinic increased to 300 miles from 50 miles, resulting in a 2.8 percent increase in births relative to what would have been expected without a ban.

For Hispanic women living 300 miles from a clinic, births increased 3.8 percent. For Black women, it was 3.2 percent, and for white women 2 percent.

“It really tracks, both that women who are poorer and younger and have less education are more likely to have an unintended pregnancy, and more likely to be unable to overcome the barriers to abortion care,” said Dr. Alison Norris, an epidemiology professor at Ohio State who helps lead a nationwide abortion counting effort and was not involved in the new study.

Advertisement

The working paper, released Monday by the National Bureau of Economic Research, is the first to analyze detailed local patterns in births soon after the Dobbs decision in 2022, a period when abortion was declining or about flat nationwide.

Unexpectedly, abortions have increased nationwide since then. Researchers say this is evidence of unmet demand for abortions before Dobbs. Since then, telehealth and a surge in financial assistance have made it easier for women to get abortions, in both states with bans and where it remained legal.

But the new findings suggest that the assistance didn’t reach everyone. State bans appear to have prevented some women from having abortions they would have sought if they were legal.

The national increase in abortion masks that some people were “trapped by bans,” said Caitlin Myers, a professor of economics at Middlebury College and an author of the paper with Daniel Dench and Mayra Pineda-Torres at Georgia Tech. “What’s happened is an increase in inequality of access: Access is increasing for some people and not for others.”

The rise in births was small, suggesting that most women who wanted abortions had still gotten them, said Diana Greene Foster, the director of research at Advancing New Standards in Reproductive Health at the University of California at San Francisco. Still, she said, the new study was persuasive in showing the effects of bans: “I now feel more convinced that some people really did have to carry pregnancies to term.”

Advertisement

John Seago, the president of Texas Right to Life, said that a federal abortion ban would work better than a patchwork of state policies, and that states like Texas needed to do more to reduce out-of-state travel and mail-order abortion pills. But he did think Texas’ law was making a difference.

“We obviously are seeing the evidence that the bans are actually preventing abortions,” he said. “They’re actually saving lives.”

Previous studies have measured changes in the abortion rate, but Professor Myers said looking at the number of babies born is the most definitive way to know whether abortion bans actually work. Research from the years before Roe was overturned showed that longer distances from clinics affected abortions and births.

“This is the paper I’ve been waiting to write for years,” she said. “These are the data I was waiting for.”

The data she wanted was detailed birth certificates filed in 2023. Mothers include information about their age, race, marital status, level of education and home address in nearly every state, making demographic comparisons possible. The researchers used a statistical method that compared places with similar birthrates before Dobbs to estimate how much a ban changed the expected birthrate.

Advertisement

They also used county-level data to look at changes in births within states. In counties in states with bans where the distance to the nearest clinic in another state didn’t change, births increased 1 percent. In counties where the distance increased by more than 200 miles, births increased 5 percent.

In Texas, the largest state with an abortion ban, births increased more in Houston, where the nearest clinic is 600 miles away in Kansas, than they did in El Paso, where the nearest clinic is 20 miles away in New Mexico. Similarly, births increased more in the South, where states are surrounded by other states with bans, but very little in eastern Missouri, where there are abortion clinics across the border in Illinois.

The researchers also looked at appointment availability at nearby clinics, because some clinics have been overrun with people traveling from other states. They found that if women were unable to get an appointment within two weeks, births increased even more.

Still, even in places with bans that had no change in distance to the nearest clinic or appointment availability there, relative births increased slightly, which Professor Myers attributed to “a chilling effect” of bans.

The findings are in line with other research. A previous analysis, using state-level data through 2023 and a different statistical method, found that births increased 1.7 percent, and more among women who were Black or Hispanic, unmarried, without college degrees, or on Medicaid.

Advertisement

“Using different methods, using slightly different data, we’re coming to the same conclusion about the disparate impacts of these policies on populations,” said Suzanne Bell, a demographer at Johns Hopkins and an author of that paper. “I think that’s adding further evidence to the notion that these are real impacts that we’re capturing.”

Since the study’s county-level data ends after 2023, it’s possible that births in states with bans have decreased since then. Abortions nationwide have continued to increase, including for women in states with bans.

Doctors in states that passed so-called shield laws, which protect them from legal liability if they send pills into states with bans, began doing so in earnest during the summer of 2023. Abortions done this way would not affect birth data until 2024.

But using provisional state-level birth data from 2024, the new paper found almost no change in births from 2023. This data is less reliable, but researchers said that even with shield laws, some women are still unlikely to get an abortion — especially those with fewer resources, who may not know about telehealth abortion sites or are wary of ordering pills online.

Advertisement

Health

New Wegovy pill offers needle-free weight loss — but may not work for everyone

Published

on

New Wegovy pill offers needle-free weight loss — but may not work for everyone

NEWYou can now listen to Fox News articles!

The first oral GLP-1 medication for weight loss has been approved for use in the U.S.

The Wegovy pill, from drugmaker Novo Nordisk, was cleared by the Food and Drug Administration to reduce excess body weight, maintain long-term weight reduction and lower the risk of major cardiovascular events.

Approval of the once-daily 25mg semaglutide pill was based on the results of two clinical trials — the OASIS trial program and the SELECT trial.

WEIGHT-LOSS DRUGS NOW LINKED TO CANCER PROTECTION IN WOMEN, MAJOR NEW STUDY REVEALS

Advertisement

The Wegovy pill demonstrated a mean weight loss of 16.6% in the OASIS 4 trial among adults who were obese or overweight and had one or more comorbidities (other medical conditions), according to a press release. In the same trial, one in three participants experienced 20% or greater weight loss.

The first oral GLP-1 medication for weight loss has been approved for use in the U.S. (iStock)

Novo Nordisk reported that the weight loss achieved with the pill is similar to that of injectable Wegovy and has a similar safety profile.

WEIGHT LOSS DRUGS COULD ADD YEARS TO AMERICANS’ LIVES, RESEARCHERS PROJECT

“With today’s approval of the Wegovy pill, patients will have a convenient, once-daily pill that can help them lose as much weight as the original Wegovy injection,” said Mike Doustdar, president and CEO of Novo Nordisk, in the press release.

Advertisement

Novo Nordisk reported that the weight loss achieved with the pill is similar to that of injectable Wegovy and has a similar safety profile. (James Manning/PA Images via Getty Images)

“As the first oral GLP-1 treatment for people living with overweight or obesity, the Wegovy pill provides patients with a new, convenient treatment option that can help patients start or continue their weight-loss journey.”

POPULAR WEIGHT-LOSS DRUGS COULD TAKE THE EDGE OFF YOUR ALCOHOL BUZZ, STUDY FINDS

The oral GLP-1 is expected to launch in the U.S. in early January 2026. Novo Nordisk has also submitted oral semaglutide for obesity to the European Medicines Agency (EMA) and other regulatory authorities.

“Most side effects will be GI-related and should be similar to the injectable, such as nausea, vomiting and constipation,” an expert said. (iStock)

Advertisement

Dr. Sue Decotiis, a medical weight-loss doctor in New York City, confirmed in an interview with Fox News Digital that studies show oral Wegovy is comparable to the weekly injectable, just without the needles.

CLICK HERE TO DOWNLOAD THE FOX NEWS APP

Although the pill may result in better compliance and ease of use, Decotiis warned that some patients may not absorb the medication through the gastrointestinal tract as well as with the injectable version due to individual idiosyncrasies in the body.

“Most side effects will be GI-related and should be similar to the injectable, such as nausea, vomiting and constipation,” she said.

CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER

Advertisement

“In my practice, I have found tirzepatide (Mounjaro and Zepbound) to yield more weight loss and fat loss than semaglutide by about 20%,” the doctor added. “This has been shown in studies, often [with] fewer side effects.”

More oral GLP-1s may be coming in 2026, according to Decotiis, including an Orforglipron application by Lilly and a new combination Novo Nordisk drug, which is pending approval later next year.

One expert warned that some patients may not absorb the medication through the gastrointestinal tract as well as with the injectable version. (iStock)

“There will be more new drugs available in the future that will be more effective for patients who are more insulin-resistant and have not responded as well to semaglutide and/or tirzepatide,” the doctor said. “This is great news, as novel drugs affecting more receptors mean better long-term results in more patients.”

TEST YOURSELF WITH OUR LATEST LIFESTYLE QUIZ

Advertisement

As these medications become cheaper and easier to access, Decotiis emphasized that keeping up with healthy lifestyle habits — including proper nutrition with sufficient protein and fiber, as well as increased hydration — is essential to ensuring lasting results.

CLICK HERE FOR MORE HEALTH STORIES

“If not, patients will regain weight and could lose muscle and not enough body fat,” she said.

Fox News Digital reached out to Novo Nordisk for comment.

Advertisement
Continue Reading

Health

Common household chemicals linked to increased risk of serious neurological condition

Published

on

Common household chemicals linked to increased risk of serious neurological condition

NEWYou can now listen to Fox News articles!

A study from Sweden’s Uppsala University discovered a link between microplastics and multiple sclerosis (MS).

The research, published in the journal Environmental International, discovered that exposure to two common environmental contaminants, PFAS and PCBs, could increase the risk of the autoimmune disease.

PFAS, or per- and polyfluoroalkyl substances, known as “forever chemicals,” are used in some common household products, such as non-stick cookware, textiles and cleaning products. They have also been found in drinking water throughout the U.S., according to the U.S. Environmental Protection Agency.

COMMON CLEANING CHEMICAL TIED TO SPIKE IN LIVER DISEASE ACROSS US, RESEARCHERS SAY

Advertisement

PCBs, or polychlorinated biphenyls, are toxic industrial chemicals once widely used in electrical equipment before being banned decades ago, as stated by the National Institute of Environmental Health Sciences.

The new study findings were based on blood samples of 1,800 Swedish individuals, including about 900 who had recently been diagnosed with MS, according to a university press release.

PFAS, or per- and polyfluoroalkyl substances, known as “forever chemicals,” are used in some common household products, including non-stick cookware. (iStock)

The first phase of the trial studied 14 different PFAS contaminants and three substances that appear when PCBs are broken down in the body. These were then investigated for a link to the odds of diagnosis.

‘FOREVER CHEMICALS’ FOUND IN US DRINKING WATER, MAP SHOWS ‘HOT SPOTS’ OF HIGHEST LEVELS

Advertisement

“We saw that several individual substances, such as PFOS and two hydroxylated PCBs, were linked to increased odds for MS,” lead study author Kim Kultima said in a statement. “People with the highest concentrations of PFOS and PCBs had approximately twice the odds of being diagnosed with MS, compared to those with the lowest concentrations.”

The researchers then examined the combined effects of these substances and found that the mixture was also linked to increased risk.

CLICK HERE FOR MORE HEALTH STORIES

Fellow researcher Aina Vaivade noted that risk assessments should consider chemical mixtures, not just individual exposures, because people are typically exposed to multiple substances at the same time.

“We saw that several individual substances, such as PFOS and two hydroxylated PCBs, were linked to increased odds for MS,” the lead study author said. (iStock)

Advertisement

The final phase of the study investigated the relationship between inheritance, chemical exposure and the odds of MS diagnosis, revealing that those who carry a certain gene variant actually have a reduced MS risk.

However, individuals who carried the gene and had higher exposure to PFOS a singular type of chemical in the PFAS family had an “unexpected” increased risk of MS.

CLICK HERE TO DOWNLOAD THE FOX NEWS APP

“This indicates that there is a complex interaction between inheritance and environmental exposure linked to the odds of MS,” Kultima said. 

“We therefore think it is important to understand how environmental contaminants interact with hereditary factors, as this can provide new knowledge about the genesis of MS and could also be relevant for other diseases.”

Advertisement

Multiple sclerosis is a disease that leads to the breakdown of the protective covering of the nerves, according to Mayo Clinic. (iStock)

Fox News senior medical analyst Dr. Marc Siegel commented on these findings in an interview with Fox News Digital.

“MS is a complex disease that is somewhat autoimmune and somewhat post-inflammatory,” said Siegel, who was not involved in the study. “Epstein-Barr virus infection greatly increases the risk of MS.”

TEST YOURSELF WITH OUR LATEST LIFESTYLE QUIZ

“There is every reason to believe that environmental triggers play a role, including microplastics, and this important study shows a correlation, but not causation — in other words, it doesn’t prove that the microplastics caused MS.”

Advertisement

The study had some limitations, the researchers acknowledged, including that the chemical exposure was measured only once, at the time of blood sampling. This means it may not accurately represent participants’ long-term or past exposure levels relevant to MS development.

“There is every reason to believe that environmental triggers play a role.”

Fox News Digital reached out to several industry groups and manufacturers requesting comment on the potential link between PFAS chemicals and multiple sclerosis. 

Several have issued public statements, including the American Chemistry Council, which states on its website that “manufacturers and many users of today’s PFAS are implementing a variety of practices and technologies to help minimize environmental emissions.”

In April 2024, the EPA enacted a new federal rule that sets mandatory limits on certain PFAS chemicals in drinking water, aiming to reduce exposure. The agency also aims to fund testing and treatment efforts.

Advertisement

A woman working out outdoors takes a sip of water from a plastic bottle. (iStock)

Multiple sclerosis is a disease that leads to the breakdown of the protective coverings that surround nerve fibers, according to Mayo Clinic.

CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER

The immune system’s attack on these nerve sheaths can cause numbness, weakness, trouble walking and moving, vision changes and other symptoms, and can lead to permanent damage.

There is currently no cure for MS, Mayo Clinic reports, but treatment is available to manage symptoms and modify the course of the disease.

Advertisement

Continue Reading

Health

Natural Ozempic? 6 GLP-1 Foods That Work Just Like the Shot

Published

on

Natural Ozempic? 6 GLP-1 Foods That Work Just Like the Shot


Advertisement


6 GLP-1 Foods That Boost Weight Loss Naturally—No Injections Needed | Woman’s World




















Advertisement











Advertisement




Use left and right arrow keys to navigate between menu items.


Use escape to exit the menu.

Advertisement

Continue Reading

Trending